Followers | 241 |
Posts | 12151 |
Boards Moderated | 3 |
Alias Born | 04/05/2009 |
Tuesday, December 30, 2014 11:24:07 PM
BioScrip Inc could be facing a proxy fight from a pair of activist investors.
The pharmacy and home health-care company changed hands recently at $6.79, up 3 percent. The shares are down 18 percent in the past six months.
Cloud Gate Capital and Delaware Street Capital Advisors, acting as a group, separately disclosed a total 6.1 percent stake in the pharmacy and home health services company Tuesday.
Each of the two affiliated investors intend to nominate new directors for election at the company's 2015 annual meeting, typically held in the spring.
Cloud Gate's David Heller and Brian Newman, together with DCS's Andrew G. Bluhm said they've held "direct communications" with BioScrip's Chairman Myron Z. Holubiak and Chief Executive Richard M. Smith concerning the plan.
The investors said they may hold discussions with the company concerning its strategic direction, operations and other issues.
Holubiak has been a director since 2005 and was named chairman in 2012. Smith joined the company in 2009 as president and was named CEO in 2011.
The company has been unprofitable in each of the past five quarters with choppy revenue.
About a year ago, BioScrip agreed to pay $15 million to settle allegations that BioScrip received kickbacks from Novartis Pharmaceuticals Corp. to promote Novartis' drug Exjade through a patient education program.
http://www.benzinga.com/news/14/12/5110983/activists-targeting-bioscrip-will-nominate-directors
"Someone said it takes 30 years to be an instant success" - Gabriel Barbier-Mueller, CEO of Harwood International
Recent BIOS News
- Medsenic, filiale de BioSenic SA, étend un brevet clé aux États-Unis • GlobeNewswire Inc. • 07/05/2024 05:00:00 AM
- Medsenic, subsidiary of BioSenic SA, extends key patent to the United States • GlobeNewswire Inc. • 07/05/2024 05:00:00 AM
- Medsenic, BioSenic’s subsidiary, signed a new set of licensing and commercialization agreements with Phebra PTY Ltd. • GlobeNewswire Inc. • 07/02/2024 05:00:00 AM
- Medsenic, filiale de BioSenic, a signé une nouvelle série d'accords de licence et de commercialisation avec Phebra PTY Ltd. • GlobeNewswire Inc. • 07/02/2024 05:00:00 AM
- BioSenic S.A. : Information on the total number of voting rights and shares • GlobeNewswire Inc. • 06/28/2024 05:00:00 AM
- BioSenic S.A. : Information relative au nombre total de droits de vote et d’actions • GlobeNewswire Inc. • 06/28/2024 05:00:00 AM
- BioSenic signe une nouvelle convention de souscription pour un maximum de 2,1 millions d'euros en obligations convertibles • GlobeNewswire Inc. • 06/21/2024 04:00:00 PM
- BioSenic signs a new subscription agreement for a maximum of EUR 2.1M in convertible bonds • GlobeNewswire Inc. • 06/21/2024 04:00:00 PM
- The Enterprise Court of Nivelles approves the BioSenic restructuring plan • GlobeNewswire Inc. • 06/14/2024 05:00:00 AM
- Le Tribunal de l'entreprise de Nivelles homologue le plan de restructuration de BioSenic • GlobeNewswire Inc. • 06/14/2024 05:00:00 AM
- BioSenic to host Annual General Meeting on July 12, 2024 • GlobeNewswire Inc. • 06/12/2024 05:00:00 AM
- BioSenic tiendra son Assemblée Générale Ordinaire le 12 juillet 2024 • GlobeNewswire Inc. • 06/12/2024 05:00:00 AM
- BioSenic announces 2023 full year results • GlobeNewswire Inc. • 06/06/2024 07:05:00 PM
- BioSenic publie ses résultats annuels 2023 • GlobeNewswire Inc. • 06/06/2024 07:05:00 PM
- BioSenic S.A. : Information on the total number of voting rights and shares • GlobeNewswire Inc. • 05/31/2024 05:00:00 AM
- BioSenic S.A. : Information relative au nombre total de droits de vote et d’actions • GlobeNewswire Inc. • 05/31/2024 05:00:00 AM
- BioSenic S.A. : Vote positif de la majorité des créanciers en faveur du plan global de restructuration de BioSenic couvrant les années 2024-2032, au Tribunal d'Entreprise de Nivelles • GlobeNewswire Inc. • 05/27/2024 03:00:00 PM
- BioSenic S.A. : Positive vote of the majority of creditors in favor of the global restructuring plan of BioSenic covering the years 2024-2032, at the Enterprise Court of Nivelles • GlobeNewswire Inc. • 05/27/2024 03:00:00 PM
- BioSenic fait le point sur ses activités du premier trimestre 2024 • GlobeNewswire Inc. • 05/24/2024 03:00:00 PM
- BioSenic provides First Quarter 2024 Business Update • GlobeNewswire Inc. • 05/24/2024 03:00:00 PM
- BioSenic S.A. : Information relative au nombre total de droits de vote et d’actions • GlobeNewswire Inc. • 04/30/2024 05:00:00 AM
- BioSenic S.A. : Information on the total number of voting rights and shares • GlobeNewswire Inc. • 04/30/2024 05:00:00 AM
- BioSenic publie sur son site web le plan de restructuration soumis au tribunal des entreprises de Nivelles • GlobeNewswire Inc. • 04/26/2024 03:30:00 PM
- BioSenic publishes on its website the restructuring plan submitted to the Enterprise Court of Nivelles • GlobeNewswire Inc. • 04/26/2024 03:30:00 PM
- BioSenic reporte son assemblée générale annuelle des actionnaires et fournit des chiffres financiers temporaires non-audités pour 2023 • GlobeNewswire Inc. • 04/24/2024 05:00:00 AM
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM